Zhou, Yi <br/><br/>
Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.  [electronic resource] 

 -  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc  Feb 2012 
 - 237-45 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1530-0285 
<br/><br/><label>Standard No.: </label>10.1038/modpathol.2011.158  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Clinical Trials as Topic<br/>Cyclophosphamide--administration & dosage<br/>Female<br/>Humans<br/>Incidence<br/>Kaplan-Meier Estimate<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasms, Second Primary--chemically induced<br/>Retrospective Studies<br/>Rituximab<br/>Vidarabine--administration & dosage